Annual Meeting GU 2016 Immune checkpoint inhibitors in combination with chemotherapy or targeted agents for urothelial cancers

Matthew Galsky, MD Director of Genitourinary Medical Oncology at the Tisch Cancer Institute discusses Immune checkpoint inhibitors in combination with chemotherapy or targeted agents for urothelial cancers at ASCO GU 2016